![](/img/cover-not-exists.png)
Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments
Caroline L. Alvares, Faith E. Davies, Clive Horton, Gita Patel, Ray Powles, Bhawna Sirohi, Roslin Zuha, Alex Gatt, Radovan Saso, Jennifer G. Treleaven, Claire E. Dearden, Michael N. Potter, Mark E. EtVolume:
129
Year:
2005
Language:
english
Pages:
8
DOI:
10.1111/j.1365-2141.2005.05514.x
File:
PDF, 211 KB
english, 2005